Institute of Dermatology, Thailand   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Bangkok Thailand (1972)

Organization Overview

First Clinical Trial
2019
NCT03800979
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Institute of Dermatology | Institute of Dermatology, Thailand

Active Ingredients

Drugs in Phase 4 Trials (1)

tofacitinib (xeljanz) (1 trial)

Drugs in Phase 3 Trials (1)

isobutylamido-thiazolyl-resorcinol (Thiamidol) (1 trial)

Drugs in Other Trials (1)

epidermal growth factor (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 4)

Alopecia Areata (Phase 4)

Facies (Phase 3)

Hyperpigmentation (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3